Liverpool researchers and clinicians attended a reception with Her Majesty the Queen Consort to mark the recent 10th anniversary of Duchenne UK, the UK’s leading Duchenne Muscular Dystrophy (DMD) Charity.
DMD is a genetic disease that causes muscle weakness and wasting. It is the most common and severe form of muscular dystrophy. DMD almost always affects boys. It is typically diagnosed in childhood between the age of three and six.
The researchers, from the University of Liverpool, Alder Hey, and the NIHR Alder Hey Clinical Research Facility (CRF) have been working with Duchenne UK for a number of years, and are involved in a range of studies, from drug trials and gene therapy, to pioneering new wheelchair designs and exoskeletons.
Dr Dan Hawcutt, Reader in Paediatric Pharmacology at the University of Liverpool, Consultant Paediatric Clinical Pharmacologist at Alder Hey Children’s Hospital and Director NIHR Alder Hey Clinical Research Facility said: “As a group of Liverpool researchers and clinicians, we are excited about continuing to work with such a forward thinking, active charity, all with the same goal: to give all those with Duchenne the rich and long life they deserve.”